+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Esomeprazole Market - Global Forecast 2026-2032- Product Image
Esomeprazole Market - Global Forecast 2026-2032- Product Image
New

Esomeprazole Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015377
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The esomeprazole market is evolving rapidly due to shifting competitive dynamics, regulatory changes, and digital innovation. Senior stakeholders face increasing complexity in optimizing supply, navigating margin pressures, and aligning product strategies to new access paradigms.

Market Snapshot: Esomeprazole Market Overview

The Esomeprazole Market grew from USD 1.94 billion in 2025 to USD 2.06 billion in 2026. It is set to maintain robust momentum, with a compound annual growth rate (CAGR) of 6.15% expected to drive the market to USD 2.95 billion by 2032.

Scope & Segmentation of the Esomeprazole Market

  • Clinical Applications: Focus on erosive esophagitis, gastroesophageal reflux disease, and NSAID-induced ulcer prevention to reflect diverse prescribing patterns and therapeutic use cases.
  • Product Types: Branded, original products and authorized generics are positioned for lifecycle management, while multi-market generics expand access in cost-driven settings.
  • Formulations: Includes capsules, oral suspensions, and tablets, optimizing treatment for both pediatric and geriatric populations and informing packaging and supply chain strategies.
  • Route of Administration: Differentiation between intravenous products for acute, inpatient scenarios and oral therapies for outpatient and chronic management.
  • Distribution Channels: Hospital, retail, and online pharmacy platforms, each requiring tailored supply reliability, point-of-care support, and digital patient engagement initiatives.
  • Region: Coverage across Americas, Europe, Middle East & Africa, and Asia-Pacific, accounting for regulatory, procurement, and market-access variances.

Key Takeaways for Senior Decision-Makers

  • Patent expirations and regulatory changes are intensifying competition by increasing generic participation and shifting price-setting strategies for both manufacturers and distributors.
  • Digital distribution channels, including online pharmacy and mobile app-based fulfillment, continue to alter patient engagement, requiring reimagined packaging, support services, and digital logistics strategies.
  • The split between intravenous and oral esomeprazole drives discrete supply chain and procurement strategies, with hospital demand for sterile products prioritizing supplier reliability and lead-time predictability.
  • Tariff fluctuations have triggered more diversified supplier relationships and encouraged nearshoring within production footprints, which enhances resilience against logistical disruptions.
  • Strategic alliances—spanning manufacturers, logistics providers, and digital pharmacy channels—are pivotal for integrated solutions that address adherence, clinical support, and cross-channel supply reliability.
  • Success increasingly requires balancing scale manufacturing capabilities, deep regulatory expertise, and commercial agility across dynamic regional and channel contexts.

Tariff Impact on Supply Chain and Procurement

Recent tariff innovations, introduced in 2025, have transformed procurement and supply strategies in the esomeprazole market. Companies have adopted supply chain diversification, accelerated nearshoring initiatives, and renegotiated supplier relationships to ensure clinical continuity and protect profitability. These strategies are especially vital where cold-chain and lead-time management are critical for sterile, intravenous formulations. Enhanced collaboration between commercial operations and logistics drives smarter inventory deployment and opens opportunities for domestic producers better able to meet evolving procurement standards.

Methodology & Data Sources

This report synthesizes insights from primary interviews with procurement leaders, hospital pharmacists, regulatory professionals, and commercial executives. Regulatory portfolio reviews and detailed supply chain analysis validate trends and scenario models. Integration of logistics, manufacturing certifications, and cost structures ensures that recommendations are grounded in operational and technical realities.

Why This Report Matters for Stakeholders

  • Informs risk mitigation through advanced supply chain intelligence and scenario-based modeling, enabling proactive responses to regulatory and tariff changes.
  • Supports strategic planning by connecting clinical value drivers to commercial execution across branded, generic, and digital distribution models.
  • Delivers actionable market segmentation to optimize product positioning, regional market entry, and channel-focused investments for manufacturers and distributors.

Conclusion

Amidst rapid market evolution, success in esomeprazole requires operational resilience, channel agility, and evidence-driven differentiation. Decision-makers can realize long-term value by aligning supply, commercial, and clinical priorities to shifting global and digital market demands.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Esomeprazole Market, by Product Type
8.1. Branded
8.1.1. Authorized Generic
8.1.2. Original Product
8.2. Generic
9. Esomeprazole Market, by Formulation
9.1. Capsules
9.2. Oral Suspension
9.3. Tablets
10. Esomeprazole Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
11. Esomeprazole Market, by Distribution Channel
11.1. Hospital Pharmacy
11.2. Online Pharmacy
11.2.1. Mobile App
11.2.2. Web Platform
11.3. Retail Pharmacy
12. Esomeprazole Market, by Application
12.1. Erosive Esophagitis
12.2. Gastroesophageal Reflux Disease
12.3. Nsaid-Induced Ulcer Prevention
13. Esomeprazole Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Esomeprazole Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Esomeprazole Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Esomeprazole Market
17. China Esomeprazole Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AstraZeneca PLC
18.6. Aurobindo Pharma Limited
18.7. Cipla Limited
18.8. Dr. Reddy's Laboratories Limited
18.9. Hikma Pharmaceuticals
18.10. Lupin Limited
18.11. Sandoz International GmbH
18.12. Sun Pharmaceutical Industries Limited
18.13. Teva Pharmaceutical Industries Limited
18.14. Viatris Inc
18.15. Zydus Lifesciences Limited
List of Figures
FIGURE 1. GLOBAL ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ESOMEPRAZOLE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ESOMEPRAZOLE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY AUTHORIZED GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY AUTHORIZED GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY AUTHORIZED GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORIGINAL PRODUCT, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORIGINAL PRODUCT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORIGINAL PRODUCT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL SUSPENSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL SUSPENSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY MOBILE APP, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY MOBILE APP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY MOBILE APP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY WEB PLATFORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY WEB PLATFORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY WEB PLATFORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY EROSIVE ESOPHAGITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY EROSIVE ESOPHAGITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY EROSIVE ESOPHAGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GASTROESOPHAGEAL REFLUX DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY NSAID-INDUCED ULCER PREVENTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY NSAID-INDUCED ULCER PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY NSAID-INDUCED ULCER PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 66. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 68. AMERICAS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 74. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 75. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 82. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. EUROPE ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. EUROPE ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 96. EUROPE ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 97. EUROPE ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 98. EUROPE ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. EUROPE ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. AFRICA ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. AFRICA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. AFRICA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 112. AFRICA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 113. AFRICA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. AFRICA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 116. AFRICA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. ASEAN ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASEAN ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 129. ASEAN ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 130. ASEAN ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. ASEAN ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. ASEAN ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 133. ASEAN ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. GCC ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. GCC ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. GCC ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 137. GCC ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 138. GCC ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. GCC ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. GCC ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 141. GCC ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. BRICS ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. BRICS ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. BRICS ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 153. BRICS ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 154. BRICS ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 155. BRICS ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. BRICS ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 157. BRICS ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. G7 ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. G7 ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. G7 ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 161. G7 ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 162. G7 ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. G7 ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. G7 ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 165. G7 ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 166. NATO ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. NATO ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. NATO ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 169. NATO ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 170. NATO ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. NATO ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 172. NATO ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 173. NATO ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL ESOMEPRAZOLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 180. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 182. UNITED STATES ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 183. CHINA ESOMEPRAZOLE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 184. CHINA ESOMEPRAZOLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 185. CHINA ESOMEPRAZOLE MARKET SIZE, BY BRANDED, 2018-2032 (USD MILLION)
TABLE 186. CHINA ESOMEPRAZOLE MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 187. CHINA ESOMEPRAZOLE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. CHINA ESOMEPRAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. CHINA ESOMEPRAZOLE MARKET SIZE, BY ONLINE PHARMACY, 2018-2032 (USD MILLION)
TABLE 190. CHINA ESOMEPRAZOLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)

Companies Mentioned

  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Hikma Pharmaceuticals
  • Lupin Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Limited
  • Viatris Inc
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.06 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.95 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Esomeprazole Capsule Market - Global Forecast 2026-2032 - Product Image

Esomeprazole Capsule Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2025-2030 - Product Image

Esomeprazole Magnesium Enteric-coated Tablets Market - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Esomeprazole (CAS 119141-88-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Proton Pump Inhibitors Market Report 2025 - Product Image

Proton Pump Inhibitors Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Gastroesophageal Reflux Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Gastroesophageal Reflux Disease - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 120 Pages
  • Global
From

About the Esomeprazole Market

Esomeprazole is a proton pump inhibitor (PPI) used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), erosive esophagitis, and Zollinger-Ellison syndrome. It works by reducing the amount of acid produced in the stomach, which helps to relieve symptoms such as heartburn, difficulty swallowing, and persistent cough. Esomeprazole is available in both prescription and over-the-counter forms. Esomeprazole is one of the most commonly prescribed PPIs, and is widely used in the treatment of GERD and other gastrointestinal disorders. It is generally well tolerated, with few side effects. It is also available in combination with other medications, such as antibiotics, to treat more severe cases of GERD. Some companies that produce esomeprazole include AstraZeneca, Pfizer, Teva Pharmaceuticals, and Mylan. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.